- £15.71m
- £19.14m
- £21.65m
- 37
- 37
- 45
- 30
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.8 | 19.5 | 18.1 | 14.7 | 21.6 |
Cost of Revenue | |||||
Gross Profit | 7.78 | 11.2 | 10.5 | 8.92 | 11.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.4 | 19.5 | 17.8 | 14 | 21.3 |
Operating Profit | -0.659 | -0.028 | 0.313 | 0.725 | 0.378 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.826 | -0.234 | 0.205 | 0.598 | -0.105 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.722 | -0.122 | 0.24 | 0.451 | -0.007 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.722 | -0.122 | 0.24 | 0.451 | -0.007 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.722 | -0.122 | 0.24 | 0.451 | -0.007 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | 0.004 | 0.006 | 0.009 | 0.005 |